Koon‐Hou Mak - Concepedia

Author

Koon‐Hou Mak

Cleveland Clinic

Also Known As

KOON‐HOU MAK, Koon-Hou Mak, KoonHou Mak, Koonhou Mak, Koon‐Hou Mak

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Cleveland Clinic Gleneagles Hospital Edinburgh Royal Infirmary National Heart Centre Singapore Brigham and Women's Hospital

About

Koon‐Hou Mak is an author at Cleveland Clinic specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	1.9K
2	Engineering	3	3	101
3	Public Health	3	3	576
4	Biomedical Engineering	2	2	87
5	Social Sciences	1	1	100

Koon‐Hou Mak

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial Deepak L. Bhatt, Marcus Flather, Werner Hacke, Journal of the American College of Cardiology Charisma TrialCardiovascular DiseasePrior Myocardial InfarctionMedicineArterial Disease Treatment	2007	799
Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France. Koon‐Hou Mak, David J. Moliterno, Christopher B. Granger, Journal of the American College of Cardiology Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseDiabetesPharmacology	1997	429
Lack of Evidence of a Clopidogrel–Statin Interaction in the CHARISMA Trial Jacqueline Saw, Danielle M. Brennan, Steven R. Steinhubl, Journal of the American College of Cardiology PharmacologyMedicineClopidogrel–statin InteractionCharisma Trial	2007	169
Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] Trial) Arijit Dasgupta, Steven R. Steinhubl, Deepak L. Bhatt, The American Journal of Cardiology ThrombosisDiabetes ManagementUrologyCardiovascular DiseaseMedicine	2009	124
Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study Koon‐Hou Mak, Deepak L. Bhatt, Mingyuan Shao, American Heart Journal ThrombosisEthnic VariationCardiovascular EpidemiologyCardiovascular DiseaseIschemic Stabilization	2008	117
Effects of a psychosocial skills training workshop on psychophysiological and psychosocial risk in patients undergoing coronary artery bypass grafting George D. Bishop, Divjyot Kaur, Vicky L.M. Tan, American Heart Journal Psychological Co-morbiditiesPsychiatryPsychophysiologyPsychosocial SkillsPsychology	2005	100
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study Deepak L. Bhatt, Guillaume Paré, John W. Eikelboom, European Heart Journal	2012	97
Coronary and mortality risk of novel oral antithrombotic agents: a meta-analysis of large randomised trials Koon‐Hou Mak BMJ Open	2012	80
Real-time interactive simulator for percutaneous coronary revascularization procedures Yaoping Wang, Chee‐Kong Chui, Honglip Lim, Computer Aided Surgery Real-time VisualizationEngineeringMedical TechnologySimulationSurgery	1998	53
Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities Koon‐Hou Mak, Emmanuelle Vidal‐Petiot, Robin Young, European Journal of Preventive Cardiology	2021	35

Page 1